CClinicalTrials.gg
CompletedNCT01162434Updated Jul 12, 2012

Brain MRI (Magnetic Resonance Imaging) Scans of Patients With Treatment Resistant Depression (TRD) and Healthy Controls

An observational study in Mental Disorders, sponsored by University of Bristol. Completed at 1 site in United Kingdom. Open to participants aged 26 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-07-12.

Sponsored by University of Bristol · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
21
Ages
26 Years to 64 Years
Sex
All
01

Study summary

Treatment resistant depression (TRD) is a major health concern, with 10% of patients with major depressive disorder not responding to conventional treatments. The investigators propose to compare the MRI (magnetic resonance imaging) brain scans of patients with TRD, which were collected during surgical planning for deep brain stimulation, with age, sex, handedness and education-matched healthy volunteer controls, to investigate anatomical differences, specifically the volume of certain brain structures.

Read the detailed description

All the patients treated at Frenchay Hospital, UK, with deep brain stimulation (DBS) for treatment resistant depression (TRD) will be given a Patient Information Sheet, and asked if they would like to participate in this research related to their condition. If they indicate they would like to participate, patients will be asked to sign a separate informed consent form (ICF) to give permission for their previously collected MRI scan to be used for this new research purpose. Information on handedness of the patients has not been previously collected, so patients will be given a short questionnaire to determine their handedness. The patients will not be required to perform any further tasks.

For each patient that agrees to participate in the study, two healthy matched control participants will be recruited. Participants will be recruited from an existing volunteer database and by local advertisements.

Respondents interested in participating will be given a letter of invite and a participant information sheet. They will be asked several basic questions including contact details, health status, age, sex, handedness, highest qualification achieved, and scanning requirements in order to assess their basic suitability for the study. If suitable, participants will be invited to attend a screening visit. Here, the informed consent form will be signed, then their medical history will be taken, and they will be given a MINI neuropsychiatric evaluation to assess their physical and mental status. Females who have the possibility of being pregnant will be asked to provide a urine sample to check they are not pregnant, and will be required to use adequate contraception until after their scan.

If suitable, participants will complete two computerised tests of mood. Then they will have a scan date booked at Frenchay hospital. At the scanning visit, participants will be assessed for any changes in health since their screening visit, and then will complete an MRI scan. The same scanner with the same sequences will be used for the healthy controls that were used for the patients. Two sequences will be collected: a coronal T1 FFE (fast field echo) volume acquisition and an axial high resolution T2 limited volume acquisition where 16 slices are collected with 8 above the ACPC (anterior commissure posterior commissure) plane and 8 below. These sequences match the sequences that our DBS patients have had and will allow both automated anatomical quantitative analysis (using Statistical Parametric Mapping version 5 (SPM5)) and quantitative description of other MRI signals such as white matter bright spots. Participants will receive no payment, but can have a printout of their scan if they wish.

The scans will then be analysed and compared to the patient scans.

02

Conditions studied

  • Mental Disorders

Keywords

  • Treatment resistant depression
  • Deep brain stimulation
  • Brain volumetric analysis
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 21 is below the median of 160 across 1,084 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Bristol is the lead sponsor of 22 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
26 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who have received Deep Brain Stimulation (DBS) for Treatment Resistant Depression at Frenchay Hospital, UK., and healthy volunteers who are matched to the DBS patients, sampled from the local area.

Inclusion criteria

  • Up to 12 females and 4 males, sex, handedness and age (±5 years) matched for the DBS patients.

Exclusion criteria

Exclusion Criteria:

  • Current or past psychiatric disorder as assessed with MINI and clinical interview.
  • Significant head injury.
  • Standard MRI risk criteria (metallic clips or pins in body, pacemaker, aneurysm clips, pregnancy, possibility of metal in eyes including history of traumatic eye injury, shrapnel or bullet injuries).
  • Inability to lie in the scanner for whatever reason (e.g. claustrophobia).
  • Current acute medical illness.
  • Started on new medicines in the last two months that the investigator feels may interfere with the study.
  • Any medical condition that in the principle investigator's opinion is not matched in the DBS sample (e.g. epilepsy, diabetes, cardiac/hepatic/renal failure but not hypertension).
  • The investigator feels that the volunteer is unsuitable for the research protocol, or unable or unwilling to comply with study procedures.
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
21 participants (actual)

Groups and cohorts

  • Patients

    Up to 8 patients who have received Deep Brain Stimulation for Treatment Resistant Depression at Frenchay Hospital (UK) will be recruited.

  • Healthy volunteers

    Up to 16 healthy volunteers, matched to the DBS patients on age, sex, handedness, and education, will be recruited.

06

What researchers measure

Primary outcomes

  1. Region of interest analysis

    Comparison of RoI volumes of specific brain structures between patients with TRD undergoing deep brain stimulation (DBS) and healthy volunteers. Specific brain regions are: hippocampus, orbitofrontal cortex and subgenual cingulate, amygdala, dorsal anterior cingulate cortex, and dorsomedial prefrontal cortex.

    Time frame: 6 months

  2. Whole brain analysis

    Whole brain MRI volumetric comparison between TRD patients undergoing DBS and healthy volunteers.

    Time frame: 6 months

  3. Comparison of abnormalities

    Comparison of other potential abnormalities e.g. areas of hyperintensity in white matter in specific brain volumes between patients with TRD undergoing DBS and healthy volunteers.

    Time frame: 6 months

07

Study locations

1 site
  • Bristol Royal Infirmary
    Bristol, BS2 8HW, United Kingdom
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01162434
Lead sponsor
University of Bristol
Collaborators
North Bristol NHS Trust
First posted
Jul 14, 2010
Start date
Feb 2010
Primary completion
Feb 2012
Completion
Feb 2012
Last update
Jul 12, 2012

Study contacts

Andrea Malizia, MD
principal investigator · University of Bristol

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion